BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, Ma S, Meermeier E, Lewinsohn DM, Sherman DR. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev 2018;31:e00021-18. [PMID: 30021818 DOI: 10.1128/CMR.00021-18] [Cited by in Crossref: 132] [Cited by in F6Publishing: 77] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Scriba TJ, Netea MG, Ginsberg AM. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis. Semin Immunol 2020;50:101431. [PMID: 33279383 DOI: 10.1016/j.smim.2020.101431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kaufmann SHE. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology. Front Immunol 2020;11:316. [PMID: 32174919 DOI: 10.3389/fimmu.2020.00316] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
3 Dwyer RA, Witte C, Buss P, Goosen WJ, Miller M. Epidemiology of Tuberculosis in Multi-Host Wildlife Systems: Implications for Black (Diceros bicornis) and White (Ceratotherium simum) Rhinoceros. Front Vet Sci 2020;7:580476. [PMID: 33330701 DOI: 10.3389/fvets.2020.580476] [Reference Citation Analysis]
4 Jakhar S, Sakamuri R, Vu D, Dighe P, Stromberg LR, Lilley L, Hengartner N, Swanson BI, Moreau E, Dorman SE, Mukundan H. Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics. PLoS One 2021;16:e0243337. [PMID: 33826643 DOI: 10.1371/journal.pone.0243337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Vernon A, Bishai W. Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith? Am J Respir Crit Care Med 2020;201:405-6. [PMID: 31765598 DOI: 10.1164/rccm.201911-2160ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Nguyen MH, Levy NS, Ahuja SD, Trieu L, Proops DC, Achkar JM. Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis. JAMA Netw Open 2019;2:e187617. [PMID: 30735231 DOI: 10.1001/jamanetworkopen.2018.7617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gupta RK, Turner CT, Venturini C, Esmail H, Rangaka MX, Copas A, Lipman M, Abubakar I, Noursadeghi M. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis. Lancet Respir Med 2020;8:395-406. [PMID: 31958400 DOI: 10.1016/S2213-2600(19)30282-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
8 Banerjee U, Baloni P, Singh A, Chandra N. Immune Subtyping in Latent Tuberculosis. Front Immunol 2021;12:595746. [PMID: 33897680 DOI: 10.3389/fimmu.2021.595746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dai Y, Shan W, Yang Q, Guo J, Zhai R, Tang X, Tang L, Tan Y, Cai Y, Chen X. Biomarkers of iron metabolism facilitate clinical diagnosis in M ycobacterium tuberculosis infection. Thorax 2019;74:1161-7. [PMID: 31611342 DOI: 10.1136/thoraxjnl-2018-212557] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
10 Mehaffy C, Kruh-Garcia NA, Graham B, Jarlsberg LG, Willyerd CE, Borisov A, Sterling TR, Nahid P, Dobos KM. Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection. J Clin Microbiol 2020;58:e00393-20. [PMID: 32245831 DOI: 10.1128/JCM.00393-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
11 Thirunavukkarasu S, Khader SA. Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis. Front Cell Infect Microbiol 2019;9:116. [PMID: 31058102 DOI: 10.3389/fcimb.2019.00116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Muñoz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger JP, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med 2020;26:1941-9. [PMID: 33077958 DOI: 10.1038/s41591-020-1076-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
13 Hunter RL. The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity. Front Immunol 2018;9:2108. [PMID: 30283448 DOI: 10.3389/fimmu.2018.02108] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
14 Sable SB, Posey JE, Scriba TJ. Tuberculosis Vaccine Development: Progress in Clinical Evaluation. Clin Microbiol Rev 2019;33:e00100-19. [PMID: 31666281 DOI: 10.1128/CMR.00100-19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 10.7] [Reference Citation Analysis]
15 Lin S, Wang Y, Li Y, Xiao D, Guo J, Ma W, An W, Liu H, Shi Y, Zhang L, Cui J, Guan W. Diagnostic Accuracy of Interleukin-27 in Bronchoalveolar Lavage Fluids for Pulmonary Tuberculosis. Infect Drug Resist 2019;12:3755-63. [PMID: 31819557 DOI: 10.2147/IDR.S231215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Meier NR, Battegay M, Ottenhoff THM, Furrer H, Nemeth J, Ritz N. HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens. Front Immunol 2021;12:620622. [PMID: 33777000 DOI: 10.3389/fimmu.2021.620622] [Reference Citation Analysis]
17 Jeon D. Latent tuberculosis infection: recent progress and challenges in South Korea. Korean J Intern Med 2020;35:269-75. [PMID: 32131570 DOI: 10.3904/kjim.2020.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Singer SN, Ndumnego OC, Kim RS, Ndung'u T, Anastos K, French A, Churchyard G, Paramithiothis E, Kasprowicz VO, Achkar JM. Plasma host protein biomarkers correlating with increasing Mycobacterium tuberculosis infection activity prior to tuberculosis diagnosis in people living with HIV. EBioMedicine 2021;75:103787. [PMID: 34968761 DOI: 10.1016/j.ebiom.2021.103787] [Reference Citation Analysis]
19 Lee GO, Paz-Soldan VA, Riley-Powell AR, Gómez A, Tarazona-Meza C, Villaizan Paliza K, Ambikapathi R, Ortiz K, Comina G, Hernandez G, Naik N, Oberhelman R, Ugarte-Gil C. Food Choice and Dietary Intake among People with Tuberculosis in Peru: Implications for Improving Practice. Curr Dev Nutr 2020;4:nzaa001. [PMID: 32025614 DOI: 10.1093/cdn/nzaa001] [Reference Citation Analysis]
20 Ruiz-Tagle C, Naves R, Balcells ME. Unraveling the Role of MicroRNAs in Mycobacterium tuberculosis Infection and Disease: Advances and Pitfalls. Infect Immun 2020;88:e00649-19. [PMID: 31871103 DOI: 10.1128/IAI.00649-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
21 Robert M, Miossec P. Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor. Cell Mol Immunol 2021;18:1644-51. [PMID: 34021269 DOI: 10.1038/s41423-021-00694-9] [Reference Citation Analysis]
22 Yang H, Lu S. COVID-19 and Tuberculosis. J Transl Int Med 2020;8:59-65. [PMID: 32983927 DOI: 10.2478/jtim-2020-0010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Barry CE, Mayer-Barber KD. Signature required: The transcriptional response to tuberculosis. J Exp Med 2021;218:e20211665. [PMID: 34779817 DOI: 10.1084/jem.20211665] [Reference Citation Analysis]
24 Zhu N, Zhou D, Li S. Diagnostic Accuracy of Metagenomic Next-Generation Sequencing in Sputum-Scarce or Smear-Negative Cases with Suspected Pulmonary Tuberculosis. Biomed Res Int 2021;2021:9970817. [PMID: 34527747 DOI: 10.1155/2021/9970817] [Reference Citation Analysis]
25 Keikha M, Karbalaei M. High resolution melting assay as a reliable method for diagnosing drug-resistant TB cases: a systematic review and meta-analysis. BMC Infect Dis 2021;21:989. [PMID: 34551717 DOI: 10.1186/s12879-021-06708-1] [Reference Citation Analysis]
26 Gopalaswamy R, Subbian S. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. Int J Mol Sci 2021;22:3773. [PMID: 33917321 DOI: 10.3390/ijms22073773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Leong S, Zhao Y, Ribeiro-Rodrigues R, Jones-López EC, Acuña-Villaorduña C, Rodrigues PM, Palaci M, Alland D, Dietze R, Ellner JJ, Johnson WE, Salgame P. Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB. Tuberculosis (Edinb) 2020;120:101898. [PMID: 32090859 DOI: 10.1016/j.tube.2020.101898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
28 Bouton TC, Jacobson KR. Symptom Screens Are Not Sufficient: The Fight Against Tuberculosis Needs Better Weapons. Clin Infect Dis 2021;73:121-3. [PMID: 32296819 DOI: 10.1093/cid/ciaa440] [Reference Citation Analysis]
29 Subbaraman R, Nathavitharana RR, Mayer KH, Satyanarayana S, Chadha VK, Arinaminpathy N, Pai M. Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care. PLoS Med 2019;16:e1002754. [PMID: 30811385 DOI: 10.1371/journal.pmed.1002754] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
30 Cho H, Park Y, Seok J, Yeom JS, Choi JY, Kim HJ, Kang YA, Lee J. Predicting the impact of control strategies on the tuberculosis burden in South and North Korea using a mathematical model. BMJ Glob Health 2021;6:e005953. [PMID: 34620614 DOI: 10.1136/bmjgh-2021-005953] [Reference Citation Analysis]
31 Nordholm AC, Lillebaek T. It is time to optimise the management of latent tuberculosis infection in children. Eur Respir J 2021;57:2004438. [PMID: 33888534 DOI: 10.1183/13993003.04438-2020] [Reference Citation Analysis]
32 Xiang L, Meng X. Emerging cellular and molecular interactions between the lung microbiota and lung diseases. Crit Rev Microbiol 2021;:1-34. [PMID: 34693852 DOI: 10.1080/1040841X.2021.1992345] [Reference Citation Analysis]
33 Steffen RE, Pinto M, Kritski A, Trajman A. Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV. Sci Rep 2020;10:21823. [PMID: 33311520 DOI: 10.1038/s41598-020-78737-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Pan SW, Su WJ, Chan YJ, Chuang FY, Feng JY, Chen YM. Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection. PLoS One 2021;16:e0253879. [PMID: 34166477 DOI: 10.1371/journal.pone.0253879] [Reference Citation Analysis]
35 Zellweger JP, Sotgiu G, Corradi M, Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Med Lav 2020;111:170-83. [PMID: 32624559 DOI: 10.23749/mdl.v111i3.9983] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
36 Schmidt CM, Lovero KL, Carvalho FR, Dos Santos DCM, Barros ACMW, Quintanilha AP, Barbosa AP, Pone MVS, Pone SM, Araujo JM, de Paula Martins C, Macedo SGD, Miceli AL, Vieira ML, Sias SMA, Queiroz A, Coca Velarde LG, Kritski AL, Silva AA, Sant'Anna CC, Riley LW, Araújo Cardoso CA. Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents. Tuberculosis (Edinb) 2020;120:101893. [PMID: 32090854 DOI: 10.1016/j.tube.2019.101893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P, Deshmukh B, Shinde V, Bishayee A, Deshmukh RR. The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives. Molecules. 2020;25. [PMID: 32630150 DOI: 10.3390/molecules25133011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
38 de Araujo LS, Ribeiro-Alves M, Leal-Calvo T, Leung J, Durán V, Samir M, Talbot S, Tallam A, Mello FCQ, Geffers R, Saad MHF, Pessler F. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection. mBio 2019;10:e01037-19. [PMID: 31796535 DOI: 10.1128/mBio.01037-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Pedersen JL, Barry SE, Bokil NJ, Ellis M, Yang Y, Guan G, Wang X, Faiz A, Britton WJ, Saunders BM. High sensitivity and specificity of a 5-analyte protein and microRNA biosignature for identification of active tuberculosis. Clin Transl Immunology 2021;10:e1298. [PMID: 34188917 DOI: 10.1002/cti2.1298] [Reference Citation Analysis]
40 Comberiati P, Di Cicco M, Paravati F, Pelosi U, Di Gangi A, Arasi S, Barni S, Caimmi D, Mastrorilli C, Licari A, Chiera F. The Role of Gut and Lung Microbiota in Susceptibility to Tuberculosis. Int J Environ Res Public Health 2021;18:12220. [PMID: 34831976 DOI: 10.3390/ijerph182212220] [Reference Citation Analysis]
41 Montecucco A, Dini G, Rahmani A, Sticchi L, Durando P. The seedbeds of Tuberculosis: is it time to target congregate settings and workplaces? J Prev Med Hyg 2020;61:E324-30. [PMID: 33150222 DOI: 10.15167/2421-4248/jpmh2020.61.3.1759] [Reference Citation Analysis]
42 Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, Mendelsohn SC, Hadley K, Hikuam C, Kaskar M, Musvosvi M, Bilek N, Self S, Sumner T, White RG, Erasmus M, Jaxa L, Raphela R, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M; CORTIS-01 Study Team. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial. Lancet Infect Dis 2021;21:354-65. [PMID: 33508224 DOI: 10.1016/S1473-3099(20)30914-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
43 Lestari BW, McAllister S, Hadisoemarto PF, Afifah N, Jani ID, Murray M, van Crevel R, Hill PC, Alisjahbana B. Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia. Lancet Reg Health West Pac 2020;5:100059. [PMID: 34327397 DOI: 10.1016/j.lanwpc.2020.100059] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol 2021;12:638047. [PMID: 33935997 DOI: 10.3389/fmicb.2021.638047] [Reference Citation Analysis]
45 Molton JS, Thomas BA, Pang Y, Khor LK, Hallinan J, Naftalin CM, Totman JJ, Townsend DW, Lim TK, Chee CBE, Wang YT, Paton NI. Sub-clinical abnormalities detected by PET/MRI in household tuberculosis contacts. BMC Infect Dis 2019;19:83. [PMID: 30678651 DOI: 10.1186/s12879-019-3705-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Darboe F, Mbandi SK, Naidoo K, Yende-Zuma N, Lewis L, Thompson EG, Duffy FJ, Fisher M, Filander E, van Rooyen M, Bilek N, Mabwe S, McKinnon LR, Chegou N, Loxton A, Walzl G, Tromp G, Padayatchi N, Govender D, Hatherill M, Karim SA, Zak DE, Penn-Nicholson A, Scriba TJ; SATVI Clinical Immunology Team. Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy. Front Microbiol 2019;10:1441. [PMID: 31297103 DOI: 10.3389/fmicb.2019.01441] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
47 Comella-Del-Barrio P, Izquierdo-Garcia JL, Gautier J, Doresca MJC, Campos-Olivas R, Santiveri CM, Muriel-Moreno B, Prat-Aymerich C, Abellana R, Pérez-Porcuna TM, Cuevas LE, Ruiz-Cabello J, Domínguez J. Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children. Sci Rep 2021;11:12006. [PMID: 34099838 DOI: 10.1038/s41598-021-91545-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, Drain PK. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis 2019;19:14. [PMID: 30611192 DOI: 10.1186/s12879-018-3614-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
49 Langer AJ, Navin TR, Winston CA, LoBue P. Epidemiology of Tuberculosis in the United States. Clin Chest Med 2019;40:693-702. [PMID: 31731978 DOI: 10.1016/j.ccm.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
50 Magcwebeba T, Dorhoi A, du Plessis N. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis. Front Immunol 2019;10:917. [PMID: 31114578 DOI: 10.3389/fimmu.2019.00917] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
51 Dijkman K, Vervenne RAW, Sombroek CC, Boot C, Hofman SO, van Meijgaarden KE, Ottenhoff THM, Kocken CHM, Haanstra KG, Vierboom MPM, Verreck FAW. Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity. Front Immunol 2019;10:2479. [PMID: 31736945 DOI: 10.3389/fimmu.2019.02479] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
52 Ahmed A, Vyakarnam A. Emerging patterns of regulatory T cell function in tuberculosis. Clin Exp Immunol 2020;202:273-87. [PMID: 32639588 DOI: 10.1111/cei.13488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Bothamley GH. Male Sex Bias in Immune Biomarkers for Tuberculosis. Front Immunol 2021;12:640903. [PMID: 33796106 DOI: 10.3389/fimmu.2021.640903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Liu Y, Wang J, Wu C. Microbiota and Tuberculosis: A Potential Role of Probiotics, and Postbiotics. Front Nutr 2021;8:626254. [PMID: 34026804 DOI: 10.3389/fnut.2021.626254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, Fisher M, Suliman S, Shankar S, Hanekom WA, Janjic N, Hatherill M, Kaufmann SHE, Sutherland J, Walzl G, De Groote MA, Ochsner U, Zak DE, Scriba TJ; ACS and GC6–74 cohort study groups. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Med 2019;16:e1002781. [PMID: 30990820 DOI: 10.1371/journal.pmed.1002781] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
56 Banaei N, Musser KA, Salfinger M, Somoskovi A, Zelazny AM. Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases. Clinics in Laboratory Medicine 2020;40:535-52. [DOI: 10.1016/j.cll.2020.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Done MM, Akkerman OW, Al-Kailany W, de Lange WCM, de Jonge G, Kleinnijenhuis J, Stienstra R, van der Werf TS. Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis. Infection 2020;48:641-5. [PMID: 32333368 DOI: 10.1007/s15010-020-01430-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 George M, Dinant GJ, Kentiba E, Teshome T, Teshome A, Tsegaye B, Spigt M. Evaluation of the performance of clinical predictors in estimating the probability of pulmonary tuberculosis among smear-negative cases in Northern Ethiopia: a cross-sectional study. BMJ Open 2020;10:e037913. [PMID: 33148731 DOI: 10.1136/bmjopen-2020-037913] [Reference Citation Analysis]
59 Hunter R, Actor J. The pathogenesis of post-primary tuberculosis. A game changer for vaccine development. Tuberculosis (Edinb) 2019;116S:S114-7. [PMID: 31076321 DOI: 10.1016/j.tube.2019.04.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
60 Cao XJ, Li YP, Wang JY, Zhou J, Guo XG. MPT64 assays for the rapid detection of Mycobacterium tuberculosis. BMC Infect Dis 2021;21:336. [PMID: 33838648 DOI: 10.1186/s12879-021-06022-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Li TL, Chan TH, Wang CH, Jou R, Yu MC, Putri DU, Lee CH, Lin YH. Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report. Infect Drug Resist 2021;14:1505-9. [PMID: 33907428 DOI: 10.2147/IDR.S304799] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Taye H, Alemu K, Mihret A, Ayalew S, Hailu E, Wood JLN, Shkedy Z, Berg S, Aseffa A; ETHICOBOTS consortium. Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia. PLoS One 2021;16:e0253480. [PMID: 34252107 DOI: 10.1371/journal.pone.0253480] [Reference Citation Analysis]
63 Espinosa J, de la Morena R, Benavides J, García-Pariente C, Fernández M, Tesouro M, Arteche N, Vallejo R, Ferreras MC, Pérez V. Assessment of Acute-Phase Protein Response Associated with the Different Pathological Forms of Bovine Paratuberculosis. Animals (Basel) 2020;10:E1925. [PMID: 33092108 DOI: 10.3390/ani10101925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Auld AF, Kerkhoff AD, Hanifa Y, Wood R, Charalambous S, Liu Y, Agizew T, Mathoma A, Boyd R, Date A, Shiraishi RW, Bicego G, Mathebula-Modongo U, Alexander H, Serumola C, Rankgoane-Pono G, Pono P, Finlay A, Shepherd JC, Ellerbrock TV, Grant AD, Fielding K. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study. PLoS Med 2021;18:e1003739. [PMID: 34491987 DOI: 10.1371/journal.pmed.1003739] [Reference Citation Analysis]
65 Nelson KN, Gandhi NR, Mathema B, Lopman BA, Brust JCM, Auld SC, Ismail N, Omar SV, Brown TS, Allana S, Campbell A, Moodley P, Mlisana K, Shah NS, Jenness SM. Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. Am J Epidemiol 2020;189:735-45. [PMID: 32242216 DOI: 10.1093/aje/kwaa028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Ku CC, MacPherson P, Khundi M, Nzawa Soko RH, Feasey HRA, Nliwasa M, Horton KC, Corbett EL, Dodd PJ. Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data. BMC Med 2021;19:298. [PMID: 34753468 DOI: 10.1186/s12916-021-02128-9] [Reference Citation Analysis]
67 Riou C, Du Bruyn E, Ruzive S, Goliath RT, Lindestam Arlehamn CS, Sette A, Sher A, Barber DL, Wilkinson RJ. Disease extent and anti-tubercular treatment response correlates with Mycobacterium tuberculosis-specific CD4 T-cell phenotype regardless of HIV-1 status. Clin Transl Immunology 2020;9:e1176. [PMID: 33005414 DOI: 10.1002/cti2.1176] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
68 Biswas S, Uddin MKM, Paul KK, Ather MF, Ahmed S, Nasrin R, Kabir S, Heysell SK, Banu S. Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh: Xpert Ultra for M. tuberculosis detection in Xpert-negative PTB presumptives. Int J Infect Dis 2021:S1201-9712(21)00856-0. [PMID: 34774779 DOI: 10.1016/j.ijid.2021.11.010] [Reference Citation Analysis]
69 Hunter RL. The Pathogenesis of Tuberculosis-The Koch Phenomenon Reinstated. Pathogens 2020;9:E813. [PMID: 33020397 DOI: 10.3390/pathogens9100813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
70 Kendall EA, Shrestha S, Dowdy DW. The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal. Am J Respir Crit Care Med 2021;203:168-74. [PMID: 33197210 DOI: 10.1164/rccm.202006-2394PP] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
71 Xie Y, Xie J, Meijer AH, Schaaf MJM. Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages. Front Immunol 2021;12:618569. [PMID: 34046029 DOI: 10.3389/fimmu.2021.618569] [Reference Citation Analysis]
72 Saralahti AK, Uusi-Mäkelä MIE, Niskanen MT, Rämet M. Integrating fish models in tuberculosis vaccine development. Dis Model Mech 2020;13:dmm045716. [PMID: 32859577 DOI: 10.1242/dmm.045716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Tabone O, Verma R, Singhania A, Chakravarty P, Branchett WJ, Graham CM, Lee J, Trang T, Reynier F, Leissner P, Kaiser K, Rodrigue M, Woltmann G, Haldar P, O'Garra A. Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis. J Exp Med 2021;218:e20210915. [PMID: 34491266 DOI: 10.1084/jem.20210915] [Reference Citation Analysis]
74 Fernández-Carballo BL, Broger T, Wyss R, Banaei N, Denkinger CM. Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis. J Clin Microbiol 2019;57:e01234-18. [PMID: 30404942 DOI: 10.1128/JCM.01234-18] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
75 Plumlee CR, Duffy FJ, Gern BH, Delahaye JL, Cohen SB, Stoltzfus CR, Rustad TR, Hansen SG, Axthelm MK, Picker LJ, Aitchison JD, Sherman DR, Ganusov VV, Gerner MY, Zak DE, Urdahl KB. Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis. Cell Host Microbe 2021;29:68-82.e5. [PMID: 33142108 DOI: 10.1016/j.chom.2020.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
76 Wong EB. It Is Time to Focus on Asymptomatic Tuberculosis. Clin Infect Dis 2021;72:e1044-6. [PMID: 33283223 DOI: 10.1093/cid/ciaa1827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Burugina Nagaraja S, Thekkur P, Satyanarayana S, Tharyan P, Sagili KD, Tonsing J, Rao R, Sachdeva KS. Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme. Trop Med Infect Dis 2021;6:206. [PMID: 34941662 DOI: 10.3390/tropicalmed6040206] [Reference Citation Analysis]
78 Baguma R, Mbandi SK, Rodo MJ, Erasmus M, Day J, Makhethe L, de Kock M, van Rooyen M, Stone L, Bilek N, Steyn M, Africa H, Darboe F, Chegou NN, Tromp G, Walzl G, Hatherill M, Penn-Nicholson A, Scriba TJ. Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults. Front Immunol 2021;12:639965. [PMID: 33717192 DOI: 10.3389/fimmu.2021.639965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Buonsenso D, Delogu G, Perricone C, Grossi R, Careddu A, De Maio F, Palucci I, Sanguinetti M, Valentini P, Sali M. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children. J Clin Microbiol 2020;58:e00272-20. [PMID: 32229602 DOI: 10.1128/JCM.00272-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
80 Ledesma JR, Ma J, Zheng P, Ross JM, Vos T, Kyu HH. Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis. BMC Infect Dis 2021;21:467. [PMID: 34022827 DOI: 10.1186/s12879-021-06141-4] [Reference Citation Analysis]
81 Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, Grewal HMS, Vaz M, Jenum S. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infect Dis 2020;20:96. [PMID: 32005136 DOI: 10.1186/s12879-020-4800-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Park JH, Shim D, Kim KES, Lee W, Shin SJ. Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against Mycobacterium tuberculosis Infection. Front Cell Infect Microbiol 2021;11:635335. [PMID: 33796480 DOI: 10.3389/fcimb.2021.635335] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Xu Y, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, Bosque M, Camarena JJ, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodríguez O, Gil-Brusola A, Gimeno C, Gimeno-Gascón A, Gomila-Sard B, González-Granda D, Gonzalo-Jiménez N, Guna-Serrano MR, López-Hontangas JL, Martín-González C, Moreno-Muñoz R, Navarro D, Navarro M, Orta N, Pérez E, Prat J, Rodríguez JC, Ruiz-García MM, Vanaclocha H, Colijn C, Comas I. High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain. PLoS Med 2019;16:e1002961. [PMID: 31671150 DOI: 10.1371/journal.pmed.1002961] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
84 Emery JC, Richards AS, Dale KD, McQuaid CF, White RG, Denholm JT, Houben RMGJ. Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease. Proc Biol Sci 2021;288:20201635. [PMID: 33467995 DOI: 10.1098/rspb.2020.1635] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
85 Min J, Chung C, Jung SS, Park HK, Lee SS, Lee KM. Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea. BMC Pulm Med 2020;20:316. [PMID: 33267859 DOI: 10.1186/s12890-020-01351-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Kwan PKW, Periaswamy B, De Sessions PF, Lin W, Molton JS, Naftalin CM, Naim ANM, Hibberd ML, Paton NI. A blood RNA transcript signature for TB exposure in household contacts. BMC Infect Dis 2020;20:403. [PMID: 32517725 DOI: 10.1186/s12879-020-05116-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Chen RY, Yu X, Smith B, Liu X, Gao J, Diacon AH, Dawson R, Tameris M, Zhu H, Qu Y, Zhang R, Pan S, Jin X, Goldfeder LC, Cai Y, Arora K, Wang J, Vincent J, Malherbe ST, Thienemann F, Wilkinson RJ, Walzl G, Barry CE 3rd. Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis. Lancet Microbe 2021;2:e518-26. [PMID: 34617068 DOI: 10.1016/S2666-5247(21)00058-6] [Reference Citation Analysis]